News
5 May 2020
Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities
Nemera today announced that they have entered into an agreement to
acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in
the development and manufacturing of injection devices. Their range of
reusable and disposable pen injectors are tailored for the treatment of
several chronic pathologies.
This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe.
Mentioned Companies
Nemera
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance